Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres

Date: Thursday 28 - Saturday 30 January 2021
Venue: Centre Expo Congres Mandelileu, France

Until recently, information on the biology of MDS and options available for its treatment were limited. However, a lot of data has accumulated in recent years on the pathophysiology of MDS, in particular as regards the role of somatic mutations (including in very early disease phase), haploinsufficiency for certain genes, and the impact of abnormalities of the microenvironment. Prognostic factors of the disease have also been refined with the revised IPSS and new factors such as somatic mutations. Treatment approaches are improving although not at the same speed, and only allogeneic stem cell transplantation remains potentially curative.
The 7th ESH Conference on MDS is designed to provide time and multiple opportunities for critical discussion and informal scientific interaction with internationally recognised experts in the field.

Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates. In separate sessions results from both basic and clinical research will be presented.

Posters and Brief Oral Communications:
Registered participants are invited to submit their biology and clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline Wednesday 19 February 2020

This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives.
  • An emphasis on in-depth scientific discussion
  • Opportunities for informal face-to-face scientific interaction with global authorities in the field.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training

Learning Objectives:

  • Learn how to optimally diagnose MDS, by morphological analysis and cytogenetics but also through the use of new tools, mainly for molecular analysis.
  • Improve ability to analyse prognostic factors, including new factors (revised IPSS, molecular analysis).
  • Review current treatment of MDS in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
  • Acquire improved knowledge of emerging treatments based on targeted therapies and well conducted clinical trials.


  • Aetiology of MDS
  • Biology of MDS: Genetic abnormalities
  • Biology of MDS: Stem cells and the microenvironment
  • Diagnostic workup and prognostic factors in MDS
  • Specific subtypes of MDS, based on morphology and molecular biology
  • Treatment of MDS
  • Current progress in the treatment of MDS
  • Future treatments and treatment strategies in MDS?

The program will include:

  • Plenary Sessions
  • Simultaneous Meet the Experts Sessions
  • Poster Walks
  • Brief Oral Communications
  • Controversial Debates
  • Ample time for in-depth discussion
  • For further information and to register your place please visit the conference website or email Oriane Rosedel

External Events

Nov 20
Jan 21
Feb 21
Mar 21
May 22
November 4th 2020
BSBMTCT Education Day
An update day for anyone working in the field of Bone Marrow Transplantation. Suitable for Transplant Directors, Consult…
November 6th 2020
How to Diagnose and Treat: Lymphoma
Chairs: Christian Buske, Catherine Thieblemont, Anas Younes
November 6th 2020
Post-transplant Managing Quality of Life Symposium…
This symposium will highlight the importance of a multidisciplinary approach for improving patients Quality of Life post…
November 11th 2020
UKMF Autumn Day
The theme of this virtual meeting is Accelerating Research: Better Trial Designs, Better Therapies. Suitable for Consult…
November 12th 2020
UKFHD 50th Academic Meeting
An update in aspects of Haemoglobin Disorders suitable for Consultants, Trainees, Nurses, Data Coordinators, Midwives, S…
November 13th 2020
Translational Research Conference: Bone Marrow Fai…
Chairs: Tim Brümmendorf, Carlo Dufour, Inderjeet Dokal, Régis Peffault de la Tour, Marc H.G.P Raaijmakers, Neal Young
November 17th 2020
1st Translational Research Conference: Chronic Lym…
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek
November 17th 2020
Current Thinking in Haematological Malignancies -…
This meeting will provide attendees with updates in current issues within the management of diseases affecting haematolo…
November 18th 2020
A User Guide to Cancer Immunotherapy
This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-me…
November 23rd 2020
Introduction to Haematology Care
This study day will provide a basic understanding of caring for haematology patients and expand knowledge on the disease…
November 24th 2020
The Royal Marsden Haemato-Oncology Study Day
This study day is aimed at healthcare professionals involved in the treatment of patients with haematological cancers, p…
November 26th 2020
Transplant Complications and GVHD
Updates in transplant complications and GVHD suitable for any member of the BMT team
November 26th 2020
Advances in Transfusion Medicine
There are exciting ongoing developments in transfusion medicine and science with high quality research supporting eviden…
November 27th 2020
HMDS Annual Haematopathology Update Day
The study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferation…
November 27th 2020
Current Thinking in Haematological Malignancies -…
This programme is designed to combine high calibre lectures and interactive discussions to provide an educational opport…
November 27th 2020
Current Thinking in Haematological Malignancies in…
High calibre lectures and interactive discussions. Suitable for consultants, trainees, nurses, pharmacists,scientists an…
January 28th 2021
7th Translational Research Conference: Myelodyspla…
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres
February 2nd 2021
Targeted Treatments for Haematological Cancers
This course describes the unique cellular and genetic features of haematological cancers and covers a diverse range of t…
March 11th 2021
Symposium on the contributions by the Anthony Nola…
An outstanding symposium for BMT and future of haematological malignancies in innovative cell therapies.
May 13th 2022
9th Translational Research Conference: Myeloprolif…
Chairs: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi